What is Chongqing Taiji Industry(Group) Co.,Ltd's (600129.SS) StockRank?

MoatMap's StockRank for Chongqing Taiji Industry(Group) Co.,Ltd (600129.SS) is 23/100, with a Sell signal. This is a composite score combining Quality (43), Value (33), and Momentum (38) factor ranks across MoatMap's 20,000+ stock universe.

Does Chongqing Taiji Industry(Group) Co.,Ltd have an economic moat?

Chongqing Taiji Industry(Group) Co.,Ltd (600129.SS) has a Quality factor score of 43/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Chongqing Taiji Industry(Group) Co.,Ltd a buy, hold, or sell?

MoatMap's current signal for Chongqing Taiji Industry(Group) Co.,Ltd (600129.SS) is Sell, based on a StockRank of 23/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Chongqing Taiji Industry(Group) Co.,Ltd in?

Chongqing Taiji Industry(Group) Co.,Ltd (600129.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

600129.SS

SELLREMOVE

Chongqing Taiji Industry(Group) Co.,Ltd · Healthcare · China · $1.2B · Avg Vol: $13M/d

StockRank

P/E (TTM)

63.9x

ROE

3.0%

D/E

1.5x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Chongqing Taiji Industry is a traditional Chinese medicine manufacturer. It lacks structural alignment with our high-conviction themes and operates in a heavily regulated domestic market with limited global scalability.

COMPANY DESCRIPTION

Chongqing Taiji Industry is a leading pharmaceutical group in China, specializing in the research, manufacture, and distribution of Traditional Chinese Medicine (TCM) and generic drugs. The company possesses a highly recognized brand portfolio, including OTC household staples, and operates an extensive retail pharmacy network. Its integration under the Sinopharm group enhances its distribution reach and R&D capabilities.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	2.1B	2.3B	1.8B	1.6B	-9.4%
EPS	0.09	0.22	0.01	0.03	-29.9%
Shares	557M	557M	557M	551M	-1.0%
Debt	677M	624M	753M	803M	5.9%
Equity	456M	535M	516M	518M	4.3%
Op CF	263M	99M	-93M	86M	-31.0%
Inv CF	-52M	-93M	-120M	-57M	—
Fin CF	-58M	-54M	69M	8M	—

PRICE (1M)-14.8%

SMA 50SMA 200

$1.95

RSI (14)

35.0

52W High

$3.77

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

7.6%65.8

ROE

3.0%50.9

GP/Assets

21.8%50.0

Op. Margin

3.8%52.1

FCF/Assets

-0.7%48.1

Piotroski

—55.7

Int. Cover

2.6x47.9

D/E Ratio

1.49x8.7

Current Ratio

0.74x4.2

Value

P/E (TTM)

63.9x15.3

EV/EBITDA

19.7x19.1

P/FCF

—N/A

P/B

2.1x54.1

P/S

0.7x88.5

Div Yield

—N/A

Momentum

52W High %

52%25.9

RS 6M

-39%31.1

SMA 50/200

0.82x16.5

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—97.7

Q Growth

-12%30.9

FUNDAMENTALS

Market Cap

$1.2B

P/E (Forward)

7.3x

Gross Margin

30.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 600129.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
600129.SS	Chongqing Taiji Industry(Group) Co.,Ltd(you)	$1.2B	23	SELL
600812.SS	North China Pharmaceutical Company.Ltd	$1.2B	21	SELL
688221.SS	Frontier Biotechnologies Inc.	$1.1B	21	SELL
300363.SZ	Porton Pharma Solutions Ltd.	$1.2B	26	SELL
600422.SS	KPC Pharmaceuticals,Inc.	$999M	24	SELL
002099.SZ	Zhejiang Hisoar Pharmaceutical Co., Ltd.	$1.3B	21	SELL
002940.SZ	Zhejiang AngLiKang Pharmaceutical CO.,LTD.	$1.0B	25	SELL
688276.SS	Changchun BCHT Biotechnology Co.	$975M	21	SELL
300702.SZ	Zhejiang Tianyu Pharmaceutical Co., Ltd.	$989M	26	SELL
603567.SS	Heilongjiang ZBD Pharmaceutical Co., Ltd.	$994M	26	SELL

Peer medians: ROE 4.8% · P/E 27.6x · Gross margin 53.1%

Chongqing Taiji Industry(Group) Co.,Ltd (600129.SS) — Stock Score Summary

Chongqing Taiji Industry(Group) Co.,Ltd (600129.SS) has a MoatMap StockRank of 23/100 based on Quality (43/100), Value (33/100), and Momentum (38/100) factor scores. The current signal is SELL. Chongqing Taiji Industry is a traditional Chinese medicine manufacturer. It lacks structural alignment with our high-conviction themes and operates in a heavily regulated domestic market with limited global scalability.

Key Financial Metrics

Price	$1.95
Market Cap	$1.2B
P/E (TTM)	63.90
P/E (Forward)	7.29
Price/Book	2.07
Return on Equity	3.0%
Return on Invested Capital	7.6%
Debt/Equity	149.46
Gross Margin	30.7%
Operating Margin	3.8%
Revenue Growth	-10.6%
Free Cash Flow	$-2M

Chongqing Taiji Industry(Group) Co.,Ltd operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Chongqing Taiji Industry(Group) Co.,Ltd’s (600129.SS) StockRank?: MoatMap’s StockRank for Chongqing Taiji Industry(Group) Co.,Ltd (600129.SS) is 23/100, with a Sell signal. It is a composite of Quality (43), Value (33), and Momentum (38) factor ranks across MoatMap’s 20,000+ stock universe.
Does Chongqing Taiji Industry(Group) Co.,Ltd have an economic moat?: Chongqing Taiji Industry(Group) Co.,Ltd (600129.SS) has a Quality factor score of 43/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Chongqing Taiji Industry(Group) Co.,Ltd a buy, hold, or sell?: MoatMap’s current signal for Chongqing Taiji Industry(Group) Co.,Ltd (600129.SS) is Sell, based on a StockRank of 23/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Chongqing Taiji Industry(Group) Co.,Ltd in?: Chongqing Taiji Industry(Group) Co.,Ltd (600129.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).